T1	Participants 69 115	neuropsychiatric disorders later in childhood:
T2	Participants 329 488	Seventy-five infants who were randomized to receive Lactobacillus rhamnosus GG (ATCC 53103) or placebo during the first 6 mo of life were followed-up for 13 y.
T3	Participants 1329 1359	development later in childhood
